CRMD (STOCKS)
CorMedix Inc.
$8.550000
-0.190000 (-2.17%)
Prev close: $8.740000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Joseph Todisco
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $674.69M
- Employees
- 82
- P/E (TTM)
- 4.16
- P/B (TTM)
- 1.57
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
8
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$0.49 | $0.37 | +0.1180 | +31.72% |
|
Dec 2025 (Q4)
|
$0.16 | $0.83 | -0.6725 | -80.78% |
|
Sep 2025 (Q3)
|
$1.26 | $0.66 | +0.6019 | +91.46% |
|
Jun 2025 (Q2)
|
$0.28 | $0.18 | +0.1037 | +58.82% |
Financial Statements
| Revenues | $400.05M |
| Benefits Costs and Expenses | $215.04M |
| Cost Of Revenue | $32.60M |
| Costs And Expenses | $215.04M |
| Gross Profit | $343.39M |
| Nonoperating Income/Loss | -$8.66M |
| Operating Expenses | $149.71M |
| Research and Development | $23.35M |
| Other Operating Expenses | $126.36M |
| Operating Income/Loss | $193.67M |
| Income/Loss From Continuing Operations After Tax | $149.19M |
| Income/Loss From Continuing Operations Before Tax | $185.02M |
| Income Tax Expense/Benefit | $4.01M |
| Income Tax Expense/Benefit, Deferred | -$12.83M |
| Net Income/Loss | $181.01M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $181.01M |
| Net Income/Loss Available To Common Stockholders, Basic | $181.01M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $241.00K |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $2.32 |
| Diluted Earnings Per Share | $2.04 |
| Basic Average Shares | 153,699,080 |
| Diluted Average Shares | 175,521,326 |
| Assets | $815.64M |
| Current Assets | $383.11M |
| Inventory | $30.73M |
| Other Current Assets | $352.38M |
| Noncurrent Assets | $432.52M |
| Fixed Assets | $6.17M |
| Intangible Assets | $368.77M |
| Other Non-current Assets | $57.59M |
| Liabilities | $378.59M |
| Current Liabilities | $128.78M |
| Accounts Payable | $12.83M |
| Other Current Liabilities | $115.95M |
| Noncurrent Liabilities | $249.81M |
| Equity | $437.05M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $437.05M |
| Liabilities And Equity | $815.64M |
| Net Cash Flow From Operating Activities | $197.69M |
| Net Cash Flow From Operating Activities, Continuing | $197.69M |
| Net Cash Flow From Investing Activities | -$305.27M |
| Net Cash Flow From Investing Activities, Continuing | -$305.27M |
| Net Cash Flow From Financing Activities | $220.26M |
| Net Cash Flow From Financing Activities, Continuing | $220.26M |
| Net Cash Flow | $112.68M |
| Net Cash Flow, Continuing | $112.68M |
| Comprehensive Income/Loss | -$82.91K |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$82.91K |
| Other Comprehensive Income/Loss | -$82.91K |